The MiR-182-5p/NDRG1 Axis Controls Endometrial Receptivity Through the NF-κB/ZEB1/E-Cadherin Pathway
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Endometrial receptivity is essential for successful pregnancy, and its impairment is a major cause of embryo-implantation failure. MicroRNAs (miRNAs) that regulate epigenetic modifications have been associated with endometrial receptivity. However, the molecular mechanisms whereby miRNAs regulate endometrial receptivity remain unclear. Therefore, we investigated whether miR-182 and its potential targets influence trophoblast cell attachment. miR-182 was expressed at lower levels in the secretory phase than in the proliferative phase of endometrium tissues from fertile donors. However, miR-182 expression was upregulated during the secretory phase in infertile women. Transfecting a synthetic miR-182-5p mimic decreased spheroid attachment of human JAr choriocarcinoma cells and E-cadherin expression (which is important for endometrial receptivity). miR-182-5p also downregulated N-Myc downstream regulated 1 (NDRG1), which was studied further. NDRG1 was upregulated in the secretory phase of the endometrium tissues and induced E-cadherin expression through the nuclear factor-κΒ (NF-κΒ)/zinc finger E-box binding homeobox 1 (ZEB1) signaling pathway. NDRG1-overexpressing or -depleted cells showed altered attachment rates of JAr spheroids. Collectively, our findings indicate that miR-182-5p-mediated NDRG1 downregulation impaired embryo implantation by upregulating the NF-κΒ/ZEB1/E-cadherin pathway. Hence, miR-182-5p is a potential biomarker for negative selection in endometrial receptivity and a therapeutic target for successful embryo implantation.
Tan Y, Du B, Chen X, Chen M Organogenesis. 2025; 21(1):2460263.
PMID: 39988813 PMC: 11853553. DOI: 10.1080/15476278.2025.2460263.
Qin X, Yang M, Yu Y, Wang X, Zheng Y, Cai R J Anim Sci Biotechnol. 2025; 16(1):4.
PMID: 39754262 PMC: 11699789. DOI: 10.1186/s40104-024-01137-x.
The Role of NDRG1 Expression in Vasculogenic Mimicry of High-grade Gliomas.
Yang H, Qin X, Zhang R, Miao J, Cui J, Li Y J Cancer. 2024; 15(20):6631-6643.
PMID: 39668822 PMC: 11632992. DOI: 10.7150/jca.100458.
Potiris A, Stavros S, Zouganeli I, Machairiotis N, Drakaki E, Zikopoulos A Biomedicines. 2024; 12(11).
PMID: 39595182 PMC: 11592390. DOI: 10.3390/biomedicines12112618.
Sarankhuu B, Jeon H, Jeong D, Park S, Kim T, Lee S Mol Med Rep. 2024; 30(4).
PMID: 39155876 PMC: 11350624. DOI: 10.3892/mmr.2024.13308.